593 related articles for article (PubMed ID: 23766440)
1. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma.
Chan TH; Lin CH; Qi L; Fei J; Li Y; Yong KJ; Liu M; Song Y; Chow RK; Ng VH; Yuan YF; Tenen DG; Guan XY; Chen L
Gut; 2014 May; 63(5):832-43. PubMed ID: 23766440
[TBL] [Abstract][Full Text] [Related]
2. RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis.
Song Y; An O; Ren X; Chan THM; Tay DJT; Tang SJ; Han J; Hong H; Ng VHE; Ke X; Shen H; Pitcheshwar P; Lin JS; Leong KW; Molias FB; Yang H; Kappei D; Chen L
J Hepatol; 2021 Jan; 74(1):135-147. PubMed ID: 32693003
[TBL] [Abstract][Full Text] [Related]
3. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma.
Qin YR; Qiao JJ; Chan TH; Zhu YH; Li FF; Liu H; Fei J; Li Y; Guan XY; Chen L
Cancer Res; 2014 Feb; 74(3):840-51. PubMed ID: 24302582
[TBL] [Abstract][Full Text] [Related]
4. ADARs and editing: The role of A-to-I RNA modification in cancer progression.
Fritzell K; Xu LD; Lagergren J; Öhman M
Semin Cell Dev Biol; 2018 Jul; 79():123-130. PubMed ID: 29146145
[TBL] [Abstract][Full Text] [Related]
5. CDK13 RNA Over-Editing Mediated by ADAR1 Associates with Poor Prognosis of Hepatocellular Carcinoma Patients.
Dong X; Chen G; Cai Z; Li Z; Qiu L; Xu H; Yuan Y; Liu XL; Liu J
Cell Physiol Biochem; 2018; 47(6):2602-2612. PubMed ID: 29996118
[TBL] [Abstract][Full Text] [Related]
6. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
[TBL] [Abstract][Full Text] [Related]
7. Editing liver tumours.
Colnot S; Fortes P
Gut; 2014 May; 63(5):709-10. PubMed ID: 23878166
[No Abstract] [Full Text] [Related]
8. RNA editome imbalance in hepatocellular carcinoma.
Qi L; Chan TH; Tenen DG; Chen L
Cancer Res; 2014 Mar; 74(5):1301-6. PubMed ID: 24556721
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of ADAR mutant mice reveals site-specific regulation of RNA editing.
Costa Cruz PH; Kato Y; Nakahama T; Shibuya T; Kawahara Y
RNA; 2020 Apr; 26(4):454-469. PubMed ID: 31941663
[TBL] [Abstract][Full Text] [Related]
10. ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.
Chan TH; Qamra A; Tan KT; Guo J; Yang H; Qi L; Lin JS; Ng VH; Song Y; Hong H; Tay ST; Liu Y; Lee J; Rha SY; Zhu F; So JB; Teh BT; Yeoh KG; Rozen S; Tenen DG; Tan P; Chen L
Gastroenterology; 2016 Oct; 151(4):637-650.e10. PubMed ID: 27373511
[TBL] [Abstract][Full Text] [Related]
11. Adenosine Deaminases Acting on RNA Downregulate the Expression of Constitutive Androstane Receptor in the Human Liver-Derived Cells by Attenuating Splicing.
Nakano M; Fukami T; Nakajima M
J Pharmacol Exp Ther; 2019 Sep; 370(3):408-415. PubMed ID: 31270214
[TBL] [Abstract][Full Text] [Related]
12. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A
J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560
[TBL] [Abstract][Full Text] [Related]
13. ADAR1 and ADAR2 expression and editing activity during forebrain development.
Jacobs MM; Fogg RL; Emeson RB; Stanwood GD
Dev Neurosci; 2009; 31(3):223-37. PubMed ID: 19325227
[TBL] [Abstract][Full Text] [Related]
14. Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses.
George CX; Ramaswami G; Li JB; Samuel CE
J Biol Chem; 2016 Mar; 291(12):6158-68. PubMed ID: 26817845
[TBL] [Abstract][Full Text] [Related]
15. Adenosine deaminases acting on RNA, RNA editing, and interferon action.
George CX; Gan Z; Liu Y; Samuel CE
J Interferon Cytokine Res; 2011 Jan; 31(1):99-117. PubMed ID: 21182352
[TBL] [Abstract][Full Text] [Related]
16. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.
Lehmann KA; Bass BL
Biochemistry; 2000 Oct; 39(42):12875-84. PubMed ID: 11041852
[TBL] [Abstract][Full Text] [Related]
17. Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development.
Tang SJ; Shen H; An O; Hong H; Li J; Song Y; Han J; Tay DJT; Ng VHE; Bellido Molias F; Leong KW; Pitcheshwar P; Yang H; Chen L
Nat Commun; 2020 Feb; 11(1):799. PubMed ID: 32034135
[TBL] [Abstract][Full Text] [Related]
18. ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers.
Liu WH; Chen CH; Yeh KH; Li CL; Wu YJ; Chen DS; Chen PJ; Yeh SH
PLoS One; 2013; 8(12):e81922. PubMed ID: 24386085
[TBL] [Abstract][Full Text] [Related]
19. To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.
Erdmann EA; Mahapatra A; Mukherjee P; Yang B; Hundley HA
Crit Rev Biochem Mol Biol; 2021 Feb; 56(1):54-87. PubMed ID: 33356612
[TBL] [Abstract][Full Text] [Related]
20. Aberrant alternative splicing pattern of ADAR2 downregulates adenosine-to-inosine editing in glioma.
Li Z; Tian Y; Tian N; Zhao X; Du C; Han L; Zhang H
Oncol Rep; 2015 Jun; 33(6):2845-52. PubMed ID: 25873329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
